Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-521 in Primary Hypophosphatemic Rickets
NCT01237288Phase 3Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Sep 2010
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium phosphate in familial hypophosphatemia, sponsored by Zeria Pharmaceutical Co., Ltd.. Started Sep 2010; status: completed.
02
Drugs
sodium phosphate
03
Conditions
familial hypophosphatemia
Beyond the preview
Go deeper on NCT01237288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01237288.